Literature DB >> 30915949

High Rate of Serotype V Streptococcus agalactiae Carriage in Pregnant Women in Botswana.

Brady A'Hearn-Thomas1, Ameneh Khatami2,3, Tara M Randis2,3, Moses Vurayai4, Margaret Mokomane4, Tonya Arscott-Mills5,6, Francis M Banda5, Tiny Mazhani5, Thabo Lepere7, Ponatshego Gaolebale8, Seeletso Nchingane8, Anna Chamby2,3, Margaret Gegick2,3, Evan Suzman2,3, Andrew P Steenhoff9,5,6, Adam J Ratner2,3.   

Abstract

Maternal rectovaginal colonization is the major risk factor for early-onset neonatal sepsis due to Group B Streptococcus (GBS), a major cause of early life morbidity and mortality. Transmission generally occurs perinatally from colonized mothers to infants. Vaccines targeting a subset of GBS serotypes are under development, but GBS epidemiology remains poorly understood in many African nations. We performed a cross-sectional study of GBS colonization among pregnant women at two sites in Botswana, a country with minimal prior GBS carriage data. We found a rectovaginal colonization rate of 19%, comparable with studies in other regions; however, we also noted a striking predominance of serotype V (> 45% of strains). Although further studies are required to delineate the burden of invasive GBS disease in Botswana and the generalizability of type V epidemiology, these data provide a useful baseline for understanding the potential local impact of GBS prevention strategies, including vaccines.

Entities:  

Mesh:

Year:  2019        PMID: 30915949      PMCID: PMC6493924          DOI: 10.4269/ajtmh.18-0847

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

1.  Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.

Authors:  Shabir A Madhi; Clare L Cutland; Lisa Jose; Anthonet Koen; Niresha Govender; Frederick Wittke; Morounfolu Olugbosi; Ajoke Sobanjo-Ter Meulen; Sherryl Baker; Peter M Dull; Vas Narasimhan; Karen Slobod
Journal:  Lancet Infect Dis       Date:  2016-04-29       Impact factor: 25.071

2.  Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe.

Authors:  Sylvester R Moyo; Johan A Maeland; Kåre Bergh
Journal:  J Med Microbiol       Date:  2002-07       Impact factor: 2.472

3.  Population structure of human isolates of Streptococcus agalactiae from Dakar and Bangui.

Authors:  Mathieu Brochet; Elisabeth Couvé; Raymond Bercion; Jean-Marie Sire; Philippe Glaser
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

4.  Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007.

Authors:  Tami H Skoff; Monica M Farley; Susan Petit; Allen S Craig; William Schaffner; Ken Gershman; Lee H Harrison; Ruth Lynfield; Janet Mohle-Boetani; Shelley Zansky; Bernadette A Albanese; Karen Stefonek; Elizabeth R Zell; Delois Jackson; Terry Thompson; Stephanie J Schrag
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

5.  Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines.

Authors:  Sonwabile Dzanibe; Shabir A Madhi
Journal:  Expert Rev Vaccines       Date:  2018-07-13       Impact factor: 5.217

6.  Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis.

Authors:  Gary M Ginsberg; Arthur I Eidelman; Eric Shinwell; Emilia Anis; Reuven Peyser; Yoram Lotan
Journal:  Isr J Health Policy Res       Date:  2013-02-20

7.  Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.

Authors:  Violette Da Cunha; Mark R Davies; Pierre-Emmanuel Douarre; Isabelle Rosinski-Chupin; Immaculada Margarit; Sebastien Spinali; Tim Perkins; Pierre Lechat; Nicolas Dmytruk; Elisabeth Sauvage; Laurence Ma; Benedetta Romi; Magali Tichit; Maria-José Lopez-Sanchez; Stéphane Descorps-Declere; Erika Souche; Carmen Buchrieser; Patrick Trieu-Cuot; Ivan Moszer; Dominique Clermont; Domenico Maione; Christiane Bouchier; David J McMillan; Julian Parkhill; John L Telford; Gordan Dougan; Mark J Walker; Matthew T G Holden; Claire Poyart; Philippe Glaser
Journal:  Nat Commun       Date:  2014-08-04       Impact factor: 14.919

Review 8.  Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.

Authors:  Lola Madrid; Anna C Seale; Maya Kohli-Lynch; Karen M Edmond; Joy E Lawn; Paul T Heath; Shabir A Madhi; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Margaret Ip; Kirsty Le Doare; Craig E Rubens; Samir K Saha; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Stephanie Schrag
Journal:  Clin Infect Dis       Date:  2017-11-06       Impact factor: 20.999

Review 9.  Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses.

Authors:  Neal J Russell; Anna C Seale; Megan O'Driscoll; Catherine O'Sullivan; Fiorella Bianchi-Jassir; Juan Gonzalez-Guarin; Joy E Lawn; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Paul T Heath; Kirsty Le Doare; Shabir A Madhi; Craig E Rubens; Stephanie Schrag; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Samir K Saha; Margaret Ip
Journal:  Clin Infect Dis       Date:  2017-11-06       Impact factor: 9.079

10.  Improving the Sensitivity of Real-time PCR Detection of Group B Streptococcus Using Consensus Sequence-Derived Oligonucleotides.

Authors:  Ameneh Khatami; Tara M Randis; Anna Chamby; Thomas A Hooven; Margaret Gegick; Evan Suzman; Brady A'Hearn-Thomas; Andrew P Steenhoff; Adam J Ratner
Journal:  Open Forum Infect Dis       Date:  2018-07-07       Impact factor: 3.835

View more
  2 in total

1.  Determinants of Group B streptococcal virulence potential amongst vaginal clinical isolates from pregnant women.

Authors:  Lindsey R Burcham; Brady L Spencer; Lauryn R Keeler; Donna L Runft; Kathryn A Patras; Melody N Neely; Kelly S Doran
Journal:  PLoS One       Date:  2019-12-18       Impact factor: 3.240

Review 2.  Group B Streptococcal Colonization in African Countries: Prevalence, Capsular Serotypes, and Molecular Sequence Types.

Authors:  Sarah Shabayek; Patricia Ferrieri; Barbara Spellerberg
Journal:  Pathogens       Date:  2021-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.